What is Biogen Idec?

Biogen Idec is a leading global biotechnology company specializing in the development, manufacturing, and commercialization of innovative therapies for neurological diseases, autoimmune disorders, and rare genetic conditions. With a mission to transform the lives of patients, Biogen Idec focuses on researching and creating groundbreaking treatments that address unmet medical needs. The company has a strong commitment to scientific rigor, seeking advancements through rigorous clinical trials and collaborations with healthcare professionals, researchers, and patient communities. Biogen Idec's portfolio includes approved therapies for multiple sclerosis, spinal muscular atrophy, and hemophilia. Committed to sustainability, Biogen Idec also ensures responsible environmental practices, emphasizing social responsibility and ethical business practices.